Blog Posts

Jan 22, 2025, 16:17

Why Should You Get the HPV Vaccine? – Onco Intelligence

Onco Intelligence shared a post on LinkedIn:

“Why Should You Get the HPV Vaccine?

The HPV Vaccine can protect you from infections caused by the human papillomavirus which may lead to various types of Cancer.

Prevention is Better than Cure.

Stay tuned for more updates and information.”

Onco Intelligence

More posts featuring Onco Intelligence.

cancer HPV vaccine Human Papilloma Virus infections Onco Intelligence OncoDaily Oncology

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Societies

Aug 21, 2025, 23:08

Empowering Cancer Survivors Through the Believe In You Program - Sylvester Comprehensive Cancer Center

Insight

Aug 21, 2025, 20:26

Kevin Harrington Looks Forward to CONCORDE Study Results on DNA Damage Inhibitors and Radiotherapy

Voices

Aug 21, 2025, 20:00

Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding

Voices

Aug 21, 2025, 19:28

Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 15:59

George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer

Voices

Aug 21, 2025, 15:47

European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC

Insight

Aug 21, 2025, 15:37

Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer

Voices

Aug 21, 2025, 15:30

Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore

Voices

Aug 21, 2025, 15:22

Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion

Oncolibrary

Aug 21, 2025, 15:00

Breakthrough Emactuzumab Phase 3 TANGENT Trial in TGCT: SynOx Pharma Reports Enrollment Completed Ahead of Schedule

Voices

Aug 21, 2025, 14:50

Andrea Apolo Highlights the Top 5 Clinical Advances in Bladder Cancer Treatment for 2024

Insight

Aug 21, 2025, 14:47

Loay Kassem: Study Reveals BRCA Mutation Rates in Egyptian Women with Breast or Ovarian Cancer